Indications and uses
helps prevent recurrence of flaking and itching associated with dandruff. helps prevent hair loss
helps prevent recurrence of flaking and itching associated with dandruff. helps prevent hair loss
for maximum dandruff control, use every time you shampoo. wet hair, massage onto scalp, rinse, repeat if desired. for best results use at least twice a week or as directed by a doctor.
Drug Facts
Pyrithione zinc 1%
Anti-dandruff
helps prevent recurrence of flaking and itching associated with dandruff.
helps prevent hair loss
For external use only.
Keep this and all drugs out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Water, Sodium laureth sulfate, Sodium lauryl sulfate, Coco Monoethanolamide, Zinc carbonate, Glycol distearate, Dimethicone, Guar hydroxypropyltrimonium chloride, Magnesium sulfate, Sodium benzoate, Magnesium carbonate hydroxide, Benzyl alcohol, Tocopheryl acetate, FD&C Yellow No. 5, Methylchloroisothiazolinone, Methylisothiazolinone, FD&C Blue no. 1
01-800-717-2413
Dist. by
Procter & Gamble Manufactura, S. de R.L. de C.V.
San Andr`s Atoto No. 326, Naucalpan de Juarez,
Estado de Mexico, MX
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1043244 | head & shoulders 1 % Medicated Shampoo | PSN | 1 |
| 209884 | zinc pyrithione 1 % Medicated Shampoo | PSN | 1 |
| 1043244 | zinc pyrithione 10 MG/ML Medicated Shampoo [Head & Shoulders] | SBD | 1 |
| 209884 | zinc pyrithione 10 MG/ML Medicated Shampoo | SCD | 1 |
| 1043244 | Head & Shoulders 1 % Medicated Shampoo | SY | 1 |
| 1043244 | Head & Shoulders 10 MG/ML Medicated Shampoo | SY | 1 |
| 209884 | zinc pyrithione 1 % Medicated Conditioner | SY | 1 |
| 209884 | zinc pyrithione 1 % Medicated Shampoo | SY | 1 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 9869efd7-d6dd-0665-5b67-53adbe6ef15e | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 51769-141-01 | 2019-11-27 | C162847 | 48780-1 | 9855d018-eec1-cd31-e053-dbdaa90ab51a | Head and Shoulders breakage prevention |
| 51769-141-05 | 2019-11-27 | C162847 | 48780-1 | 9855d018-eec1-cd31-e053-dbdaa90ab51a | Head and Shoulders breakage prevention |
| 51769-141-11 | 2019-11-27 | C162847 | 48780-1 | 9855d018-eec1-cd31-e053-dbdaa90ab51a | Head and Shoulders breakage prevention |
| 51769-141-18 | 2019-11-27 | C162847 | 48780-1 | 9855d018-eec1-cd31-e053-dbdaa90ab51a | Head and Shoulders breakage prevention |
| 51769-141-20 | 2019-11-27 | C162847 | 48780-1 | 9855d018-eec1-cd31-e053-dbdaa90ab51a | Head and Shoulders breakage prevention |
| 51769-141-40 | 2019-11-27 | C162847 | 48780-1 | 9855d018-eec1-cd31-e053-dbdaa90ab51a | Head and Shoulders breakage prevention |
| 51769-141-50 | 2019-11-27 | C162847 | 48780-1 | 9855d018-eec1-cd31-e053-dbdaa90ab51a | Head and Shoulders breakage prevention |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51769-141-01 | Head and Shouldersbreakage prevention | 10 mL in 1 POUCH | SHAMPOO | 10 | 1 | |
| 51769-141-05 | Head and Shouldersbreakage prevention | 50 mL in 1 BOTTLE, PLASTIC | SHAMPOO | 50 | 1 | |
| 51769-141-11 | Head and Shouldersbreakage prevention | 1000 mL in 1 BOTTLE, PLASTIC | SHAMPOO | 1000 | 1 | |
| 51769-141-18 | Head and Shouldersbreakage prevention | 1180 mL in 1 BOTTLE, PLASTIC | SHAMPOO | 1180 | 1 | |
| 51769-141-20 | Head and Shouldersbreakage prevention | 200 mL in 1 BOTTLE, PLASTIC | SHAMPOO | 200 | 1 | |
| 51769-141-40 | Head and Shouldersbreakage prevention | 400 mL in 1 BOTTLE, PLASTIC | SHAMPOO | 400 | 1 | |
| 51769-141-50 | Head and Shouldersbreakage prevention | 500 mL in 1 BOTTLE, PLASTIC | SHAMPOO | 500 | 1 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Pyrithione Zinc | ACTIVE INGREDIENT | R953O2RHZ5 | 1 | |
| PYRITHIONE ZINC | ACTIVE MOIETY | R953O2RHZ5 | 1 | |
| .ALPHA.-TOCOPHEROL ACETATE | INACTIVE INGREDIENT | 9E8X80D2L0 | 1 | |
| Benzyl alcohol | INACTIVE INGREDIENT | LKG8494WBH | 1 | |
| Coco Monoethanolamide | INACTIVE INGREDIENT | C80684146D | 1 | |
| Dimethicone | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| FD&C Blue no. 1 | INACTIVE INGREDIENT | H3R47K3TBD | 1 | |
| FD&C Yellow No. 5 | INACTIVE INGREDIENT | I753WB2F1M | 1 | |
| Glycol distearate | INACTIVE INGREDIENT | 13W7MDN21W | 1 | |
| Guar hydroxypropyltrimonium chloride (1.7 substituents per saccharide) | INACTIVE INGREDIENT | B16G315W7A | 1 | |
| magnesium carbonate hydroxide | INACTIVE INGREDIENT | YQO029V1L4 | 1 | |
| Magnesium sulfate | INACTIVE INGREDIENT | DE08037SAB | 1 | |
| methylchloroisothiazolinone | INACTIVE INGREDIENT | DEL7T5QRPN | 1 | |
| methylisothiazolinone | INACTIVE INGREDIENT | 229D0E1QFA | 1 | |
| Sodium benzoate | INACTIVE INGREDIENT | OJ245FE5EU | 1 | |
| Sodium laureth sulfate | INACTIVE INGREDIENT | BPV390UAP0 | 1 | |
| Sodium lauryl sulfate | INACTIVE INGREDIENT | 368GB5141J | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| Zinc carbonate | INACTIVE INGREDIENT | EQR32Y7H0M | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 51769-141 | 51769-141-50, 51769-141-40, 51769-141-20, 51769-141-11, 51769-141-18, 51769-141-05, 51769-141-01 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| FD&C Blue no. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | TABLET, FILM COATED / ORAL | 0.16 mg | ||
| FD&C Blue no. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | DOUCHE / VAGINAL | NA | ||
| Benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | INJECTION / INTRALESIONAL | 23 mg | ||
| FD&C Yellow No. 5 | FD&C YELLOW NO. 5 | I753WB2F1M | TABLET, DELAYED RELEASE / ORAL | 3 mg | ||
| Sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | TABLET, DELAYED RELEASE / ORAL | 0.34 mg | ||
| Benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | SPRAY, METERED / NASAL | 5 mg/1ml | ||
| Benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | SHAMPOO / TOPICAL | 1.25 %w/w | ||
| Sodium lauryl sulfate | SODIUM LAURYL SULFATE | 368GB5141J | TABLET, CHEWABLE / ORAL | 6 mg | ||
| Benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVERNOUS | 18 mg | ||
| FD&C Yellow No. 5 | FD&C YELLOW NO. 5 | I753WB2F1M | TABLET, FILM COATED / ORAL | 1.68 mg | ||
| Sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | ELIXIR / ORAL | 5.02 mg/5ml | ||
| Sodium lauryl sulfate | SODIUM LAURYL SULFATE | 368GB5141J | GEL / VAGINAL | 0.2 %w/w | ||
| Benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | INJECTION / SUBCUTANEOUS | 90 mg | ||
| FD&C Blue no. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | SOLUTION / ORAL | 1.13 mg/15ml | ||
| Sodium lauryl sulfate | SODIUM LAURYL SULFATE | 368GB5141J | TABLET, EXTENDED RELEASE / ORAL | 320 mg | ||
| Sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | INJECTION, EMULSION / INTRAVENOUS | 0.1 %w/v | ||
| Sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | INJECTION / INTRAVENOUS | 864 mg | ||
| Sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | GRANULE / ORAL | NA | ||
| Benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | LOTION / TOPICAL | 4000 mg | ||
| FD&C Blue no. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | CAPSULE, DELAYED RELEASE / ORAL | 2 mg | ||
| Sodium lauryl sulfate | SODIUM LAURYL SULFATE | 368GB5141J | CAPSULE, DELAYED RELEASE / ORAL | 46 mg | ||
| Sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | TABLET / ORAL | 30 mg | ||
| FD&C Yellow No. 5 | FD&C YELLOW NO. 5 | I753WB2F1M | TABLET / BUCCAL | 0.11 mg | ||
| Sodium laureth sulfate | SODIUM LAURETH-3 SULFATE | BPV390UAP0 | SHAMPOO / TOPICAL | 3192 mg | ||
| Sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | INJECTION, SOLUTION / INTRAMUSCULAR | 4.8 %w/v | ||
| Benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | CREAM / TOPICAL | 160 mg | ||
| Benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | INJECTION, EMULSION / SUBCUTANEOUS | 225 mg | ||
| Sodium benzoate | SODIUM BENZOATE | OJ245FE5EU | PASTE, DENTIFRICE / DENTAL | 0.5 %w/w | ||
| Sodium lauryl sulfate | SODIUM LAURYL SULFATE | 368GB5141J | LOTION / TOPICAL | 111 mg | ||
| FD&C Blue no. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | MOUTHWASH / BUCCAL | NA | ||
| FD&C Blue no. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | LOTION / TOPICAL | NA | ||
| Benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | INJECTION / INTRA-ARTICULAR | 1 %w/v | ||
| Benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | INJECTION, SUSPENSION / INTRALESIONAL | 20 mg | ||
| Benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | INJECTION / INTRAMUSCULAR | 1000 mg | ||
| Sodium laureth sulfate | SODIUM LAURETH-3 SULFATE | BPV390UAP0 | CREAM / TOPICAL | NA | ||
| Sodium laureth sulfate | SODIUM LAURETH-3 SULFATE | BPV390UAP0 | TABLET / ORAL | 0.91 mg | ||
| FD&C Blue no. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 0.01 mg | ||
| FD&C Yellow No. 5 | FD&C YELLOW NO. 5 | I753WB2F1M | CONCENTRATE / BUCCAL | NA | ||
| FD&C Yellow No. 5 | FD&C YELLOW NO. 5 | I753WB2F1M | TABLET, EXTENDED RELEASE / ORAL | 2.03 mg | ||
| Benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | SUSPENSION / ORAL | 100 mg | ||
| FD&C Blue no. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | SYRUP / ORAL | 0.05 mg/5ml | ||
| Benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | LIQUID / INTRAVENOUS | 1.04 %w/v | ||
| Benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | TABLET / ORAL | 1.06 mg | ||
| Sodium lauryl sulfate | SODIUM LAURYL SULFATE | 368GB5141J | SUSPENSION, EXTENDED RELEASE / ORAL | 0.08 mg/1ml | ||
| Sodium lauryl sulfate | SODIUM LAURYL SULFATE | 368GB5141J | PASTE / DENTAL | 1.5 %w/w | ||
| Sodium lauryl sulfate | SODIUM LAURYL SULFATE | 368GB5141J | TABLET, ORALLY DISINTEGRATING / ORAL | 16 mg | ||
| Magnesium sulfate | MAGNESIUM SULFATE | DE08037SAB | CAPSULE / ORAL | NA | ||
| Benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | INJECTION / INTRACAVITARY | 0.01 ml | ||
| FD&C Blue no. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | ELIXIR / ORAL | NA | ||
| Sodium lauryl sulfate | SODIUM LAURYL SULFATE | 368GB5141J | TABLET, DELAYED RELEASE / ORAL | 199 mg | ||
| FD&C Blue no. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | TABLET / SUBLINGUAL | 0.03 mg | ||
| Sodium lauryl sulfate | SODIUM LAURYL SULFATE | 368GB5141J | GRANULE / ORAL | 12 mg | ||
| Sodium lauryl sulfate | SODIUM LAURYL SULFATE | 368GB5141J | SPONGE / TOPICAL | 5 %w/w | ||
| Benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | INJECTION / INTRA-ARTERIAL | 0.9 %w/v | ||
| Sodium lauryl sulfate | SODIUM LAURYL SULFATE | 368GB5141J | CAPSULE, COATED PELLETS / ORAL | 1 mg | ||
| Benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | SUSPENSION / TOPICAL | 1 %w/w | ||
| Benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | CAPSULE, EXTENDED RELEASE / ORAL | 1.23 mg | ||
| FD&C Yellow No. 5 | FD&C YELLOW NO. 5 | I753WB2F1M | TABLET / ORAL | 180 mg | ||
| FD&C Blue no. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | CONCENTRATE / ORAL | NA | ||
| Magnesium sulfate | MAGNESIUM SULFATE | DE08037SAB | TABLET / ORAL | 2.9 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| f58016ec-c5ab-4943-bd2b-e85b04fac313 | 35efb2a7-b707-4fe1-9a45-0b280aac7618 | 2013-02-01 | Warnings | f58016ec-c5ab-4943-bd2b-e85b04fac313 35efb2a7-b707-4fe1-9a45-0b280aac7618 |
Adverse event summaries are temporarily unavailable. Other product information remains available.